Xenetic Biosciences Inc. (XBIO)
NASDAQ: XBIO
· Real-Time Price · USD
2.86
-0.06 (-2.22%)
At close: Aug 15, 2025, 3:58 PM
2.96
3.50%
After-hours: Aug 15, 2025, 06:02 PM EDT
Xenetic Biosciences Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 589.9K | 593.26K | 648.82K | 614.24K | 726.4K | 510.82K | 671.96K | 611.17K | 651K | 605.84K | 486.97K | 414.25K | 416.71K | 388.99K | 332.6K | 349.27K | 287.6K | 191.22K |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 7.96K | 9.61K | n/a | 9.28K | n/a | n/a | n/a |
Gross Profit | n/a | 593.26K | 648.82K | 614.24K | 726.4K | 510.82K | 671.96K | 611.17K | 651K | 605.84K | 486.97K | 406.29K | 407.1K | 388.99K | 323.32K | 349.27K | 287.6K | 191.22K |
Operating Income | -724.41K | -942.41K | -1.1M | -499.47K | -1.34M | -1.27M | -1.26M | -1.15M | -1.2M | -915.17K | -1.56M | -847.79K | -2.69M | -1.62M | -1.87M | -1.38M | -1.13M | -1.37M |
Interest Income | 34.23K | 39.19K | 51.87K | 61.3K | 63.45K | 73.25K | 83.76K | 91.8K | 126.1K | 54.1K | 79.81K | 45.48K | 15.96K | 25.91K | 29.44K | 28.03K | 20.73K | 22.26K |
Pretax Income | -688.7K | -903.14K | -1.05M | -436.67K | -1.27M | -1.2M | -1.17M | -1.06M | -1.05M | -856.55K | -1.48M | -804.02K | -2.67M | -1.59M | -1.84M | -1.35M | -1.11M | -1.35M |
Net Income | -688.7K | -903.14K | -1.05M | -436.67K | -1.27M | -1.2M | -1.17M | -1.06M | -1.05M | -797.93K | -1.38M | -760.25K | -2.64M | -1.54M | -1.84M | -1.35M | -1.11M | -1.35M |
Selling & General & Admin | 657.75K | 656.64K | 705.71K | 745.73K | 1.13M | 834.91K | 952K | 737.24K | 945.95K | 925.74K | 857.17K | 863.23K | 1.03M | 907.31K | 977.58K | 945.12K | 890.7K | 930.58K |
Research & Development | 656.56K | 879.03K | 1.04M | 367.99K | 933.77K | 944.32K | 975.63K | 1.02M | 903.24K | 595.28K | 1.19M | 398.8K | 2.08M | 1.1M | 1.23M | 780.15K | 524.55K | 629.73K |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | 404.00 | -666 | n/a | 4.52K | 986.00 | -1.71K | -1.08K | 199.00 | 2.9K | -2.91K | 238.00 | 884.00 |
Operating Expenses | 1.31M | 1.54M | 1.75M | 1.11M | 2.06M | 1.78M | 1.93M | 1.76M | 1.85M | 1.52M | 2.05M | 1.26M | 3.1M | 2.01M | 2.21M | 1.73M | 1.42M | 1.56M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 1.31M | 1.54M | 1.75M | 1.11M | 2.06M | 1.78M | 1.93M | 1.76M | 1.85M | 1.52M | 2.05M | 1.26M | 3.1M | 2.01M | 2.21M | 1.73M | 1.42M | 1.56M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -58.62K | -99.88K | -43.77K | -30.85K | -52.01K | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 1.54M | 1.54M | 1.54M | 1.54M | 1.54M | 1.54M | 1.54M | 1.53M | 1.52M | 1.52M | 1.52M | 1.27M | 1.27M | 1.27M | 1.02M | 1.02M | 851.29K | 874.63K |
Shares Outstanding (Diluted) | 1.54M | 1.54M | 1.54M | 1.54M | 1.54M | 1.54M | 1.54M | 1.53M | 1.52M | 1.52M | 1.52M | 1.27M | 1.27M | 1.27M | 1.02M | 1.02M | 874.67K | 874.63K |
EPS (Basic) | -0.45 | -0.59 | -0.68 | -0.28 | -0.83 | -0.78 | -0.76 | -0.69 | -0.69 | -0.53 | -0.91 | -0.6 | -2.08 | -1.21 | -1.8 | -1.33 | -1.3 | -1.54 |
EPS (Diluted) | -0.45 | -0.59 | -0.68 | -0.28 | -0.83 | -0.78 | -0.76 | -0.69 | -0.69 | -0.53 | -0.91 | -0.6 | -2.08 | -1.21 | -1.8 | -1.33 | -1.27 | -1.54 |
EBITDA | -724.41K | -942.41K | -1.1M | -499.47K | -1.34M | -1.27M | -1.26M | -1.15M | -1.2M | -915.17K | -1.55M | -847.79K | -2.68M | -1.62M | -1.87M | -1.37M | -1.12M | -1.36M |
EBIT | -688.7K | -942K | -1.1M | -499.47K | -1.34M | -1.27M | -1.26M | -1.15M | -1.2M | -915.17K | -1.56M | -847.79K | -2.69M | -1.62M | -1.87M | -1.38M | -1.13M | -1.37M |
Depreciation & Amortization | n/a | n/a | n/a | n/a | n/a | -10.62K | -7.85K | 7.64K | 2.86K | 12.92K | 18.2K | 7.96K | 9.61K | 9.47K | 9.28K | 9.04K | 8.75K | 8.41K |